Cargando…
Analysis of the clinical significance of DCLK1(+) colorectal cancer using novel monoclonal antibodies against DCLK1
INTRODUCTION: Doublecortin-like kinase 1 (DCLK1) is considered a putative tumor stem cell (TSC) marker and a promising therapeutic target, as DCLK1(+) progeny cells exhibit high expression in tumors. However, the biological function of DCLK1(+) cells in tumorigenesis and tumor progression remains un...
Autores principales: | Dai, Tianqi, Hu, Yunlong, Lv, Fulian, Ozawa, Tatsuhiko, Sun, Xin, Huang, Jingjing, Han, Xiaojian, Kishi, Hiroyuki, Muraguchi, Atsushi, Jin, Aishun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110630/ https://www.ncbi.nlm.nih.gov/pubmed/30174443 http://dx.doi.org/10.2147/OTT.S169928 |
Ejemplares similares
-
DCLK1 immunoreactivity in colorectal neoplasia
por: Gagliardi, Giuseppe, et al.
Publicado: (2012) -
DCLK1 autoinhibition and activation in tumorigenesis
por: Cheng, Linna, et al.
Publicado: (2021) -
Structural Basis of Inhibition of DCLK1 by Ruxolitinib
por: Jang, Dong Man, et al.
Publicado: (2021) -
DCLK1 Inhibition Sensitizes Colorectal Cancer Cells to Radiation Treatment
por: Mohammadi, Chiman, et al.
Publicado: (2021) -
DCLK1 Monoclonal Antibody-Based CAR-T Cells as a Novel Treatment Strategy against Human Colorectal Cancers
por: Sureban, Sripathi M., et al.
Publicado: (2019)